Literature DB >> 11991817

Monoclonal antibodies selective for low molecular weight neurofilaments.

Niklas Norgren1, Jan-Erik Karlsson, Lars Rosengren, Torgny Stigbrand.   

Abstract

Neurofilaments are necessary for the maintenance of axonal caliber and structural organization of nerve cells. The low molecular weight form of neurofilament, the neurofilament light protein, which serves as the core of the filament, was used as immunogen for generation of hybridomas with selective reactivity with this form of the filament. Six hybridomas, out of approximately 100 tested clones, were highly discriminatory. All involved epitopes were localized to the rod region of the antigen, as determined by alpha-chymotrypsin digestion of the purified filament and enzymatic peptide mapping. Synthetic peptides (20 mers) covering the entire rod region did not react with the antibodies. A phage display peptide library was used to identify four consensus sequences for the antibodies. The results indicate that all epitopes were of conformational type. Pair-wise BIAcore data furthermore indicated that the epitopes were independent. The access to such specific reagents is a prerequisite for further elucidation of the biology of the low molecular weight form of neurofilaments proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991817     DOI: 10.1089/15368590252917647

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  22 in total

1.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

2.  Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.

Authors:  M Axelsson; C Malmeström; S Nilsson; S Haghighi; L Rosengren; J Lycke
Journal:  J Neurol       Date:  2011-01-01       Impact factor: 4.849

3.  A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.

Authors:  Shreyasee Das; Nele Dewit; Dirk Jacobs; Yolande A L Pijnenburg; Sjors G J G In 't Veld; Salomé Coppens; Milena Quaglia; Christophe Hirtz; Charlotte E Teunissen; Eugeen Vanmechelen
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

4.  Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.

Authors:  Carlo Wilke; David Mengel; Ludger Schöls; Holger Hengel; Maria Rakowicz; Thomas Klockgether; Alexandra Durr; Alessandro Filla; Bela Melegh; Rebecca Schüle; Kathrin Reetz; Heike Jacobi; Matthis Synofzik
Journal:  Neurology       Date:  2022-03-09       Impact factor: 11.800

Review 5.  Neurofilaments in disease: what do we know?

Authors:  Brian A Gordon
Journal:  Curr Opin Neurobiol       Date:  2020-03-06       Impact factor: 6.627

Review 6.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

7.  Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Authors:  Oliver Preische; Stephanie A Schultz; Anja Apel; Jens Kuhle; Stephan A Kaeser; Christian Barro; Susanne Gräber; Elke Kuder-Buletta; Christian LaFougere; Christoph Laske; Jonathan Vöglein; Johannes Levin; Colin L Masters; Ralph Martins; Peter R Schofield; Martin N Rossor; Neill R Graff-Radford; Stephen Salloway; Bernardino Ghetti; John M Ringman; James M Noble; Jasmeer Chhatwal; Alison M Goate; Tammie L S Benzinger; John C Morris; Randall J Bateman; Guoqiao Wang; Anne M Fagan; Eric M McDade; Brian A Gordon; Mathias Jucker
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

8.  Serum neurofilament light is sensitive to active cerebral small vessel disease.

Authors:  Thomas Gattringer; Daniela Pinter; Christian Enzinger; Thomas Seifert-Held; Markus Kneihsl; Simon Fandler; Alexander Pichler; Christian Barro; Svenya Gröbke; Margarete Voortman; Lukas Pirpamer; Edith Hofer; Stefan Ropele; Reinhold Schmidt; Jens Kuhle; Franz Fazekas; Michael Khalil
Journal:  Neurology       Date:  2017-10-18       Impact factor: 9.910

Review 9.  Neurofilaments: neurobiological foundations for biomarker applications.

Authors:  Arie R Gafson; Nicolas R Barthélemy; Pascale Bomont; Roxana O Carare; Heather D Durham; Jean-Pierre Julien; Jens Kuhle; David Leppert; Ralph A Nixon; Roy O Weller; Henrik Zetterberg; Paul M Matthews
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

10.  CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Authors:  Sahra Abdulle; Asa Mellgren; Bruce J Brew; Paola Cinque; Lars Hagberg; Richard W Price; Lars Rosengren; Magnus Gisslén
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.